Janssen pharma collaborates with Beth Israel Deaconess Medical Center for COVID-19 Vaccine Development Medical Dialogues Bureau14 March 2020 4:00 AMJanssen's vaccine program will use the Janssen AdVac® and PER.C6® technologies that provide the ability to rapidly upscale production of an optimal...
HC relief to J&J: stays order directing co to pay Rs 230 crore on account of GST profiteering Medical Dialogues Bureau5 March 2020 7:15 AMIt also said that prima facie the methodology used by NAPA to arrive at its finding of profiteering was "flawed".
JnJ Faulty Hip Implants: 171 patients received compensation, says Ashwini Kumar Choubey Medical Dialogues Bureau5 Feb 2020 9:45 AM "Based on the court order, a list of verified claimants along with supporting documents has been provided to Johnson and Johnson for complying with...
Drugmajors slash prices by 53pc for China bulk-buy program eligibility Medical Dialogues Bureau20 Jan 2020 4:30 AMBeijing: Global pharmaceutical majors and generic drugmakers chopped by 53% on average prices of some of their off-patent products in the latest...
AstraZeneca leukemia drug Calquence gets USFDA okay Medical Dialogues Bureau24 Nov 2019 4:30 AMNew Delhi: AstraZeneca said late on Thursday that the U.S. Food and Drug Administration (FDA) had given its go-ahead for the company's Calquence drug...
JnJ enters series of new collaborations with Government, NGOs for ending TB in India by 2025 Farhat Nasim31 Oct 2019 7:09 AMHyderabad: Johnson & Johnson(JnJ) recently announced the expansion of its tuberculosis (TB) program in India in advance of the 50th Union World...
New tests shows NO sign of asbestos in recalled JnJ baby powder Medical Dialogues Bureau30 Oct 2019 7:48 AMBut Johnson & Johnson (JnJ) said in a statement that dozens of tests by two outside firms did not detect any asbestos in JnJ's baby powder.New...
Johnson and Johnson hit with whooping USD 8 billion verdict over antipsychotic drug Risperda Medical Dialogues Bureau9 Oct 2019 10:54 AMJohnson and Johnson said the award was "grossly disproportionate with the initial compensatory award in this case, and the company is confident it...
JnJ pledges USD 500 million investment to eliminate HIV, TB by 2030 Medical Dialogues Bureau7 Oct 2019 4:00 AMNEW BRUNSWICK: Johnson & Johnson (JnJ) recently announced it has committed to ensuring more than $500 million is dedicated to world-class research...
22-member Committee Constituted to guide CDSCO on Medical Device Regulation Farhat Nasim27 July 2019 7:39 AMNew Delhi: To advice the apex drug regulator, Central Drugs Standard Control Organisation (CDSCO) on matters related to the regulation and...
Natco Pharma files ANDA for generic version of Bosentan tablets for oral suspension Farhat Nasim5 Jun 2019 4:30 AMBosentan 32 mg tablets are sold by Actelion Pharmaceuticals US, Inc. (acquired by Johnson and Johnson) under the brand name Tracleer.Hyderabad:...
MORE TEARS: After Talcum Powder, JnJ Baby Shampoo reveals presence of Carcinogens Meghna A Singhania3 April 2019 11:00 AMNew Delhi: After facing trouble with its baby talcum powder amid allegations that it contains asbestos, US healthcare giant Johnson and Johnson (JnJ)...
